within Pharmacolibrary.Drugs.P_AntiparasiticProductsInsecticidesAndRepellents.P01C_AgentsAgainstLeishmaniasisAndTrypanosomiasis.P01CC01_Nifurtimox;

model Nifurtimox
  extends Pharmacolibrary.Drugs.ATC.P.P01CC01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>P01CC01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Nifurtimox is a nitrofuran derivative used primarily for the treatment of Chagas disease (American trypanosomiasis), caused by Trypanosoma cruzi. It has antiparasitic activity and is sometimes used off-label for other trypanosomal diseases. Nifurtimox has been approved for use in several countries, but is often reserved for cases where benznidazole is not available or appropriate.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adults after oral administration; data primarily from non-compartmental and compartmental PK studies.</p><h4>References</h4><ol><li><p>Schulz, SI, et al., &amp; Stass, H (2023). . <i>Current drug metabolism</i> 24(8) 599–610. DOI:<a href=&quot;https://doi.org/10.2174/1389200224666230817114758&quot;>10.2174/1389200224666230817114758</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37592798/&quot;>https://pubmed.ncbi.nlm.nih.gov/37592798</a></p></li><li><p>Lang, D, et al., &amp; Stass, H (2022). Structural and Mechanistic Investigation of the Unusual Metabolism of Nifurtimox. <i>Chemical research in toxicology</i> 35(11) 2037–2048. DOI:<a href=&quot;https://doi.org/10.1021/acs.chemrestox.2c00210&quot;>10.1021/acs.chemrestox.2c00210</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36209416/&quot;>https://pubmed.ncbi.nlm.nih.gov/36209416</a></p></li><li><p>Amilon, C, et al., &amp; Jansson-Löfmark, R (2022). Population Pharmacodynamic Modeling of Eflornithine-Based Treatments Against Late-Stage Gambiense Human African Trypanosomiasis and Efficacy Predictions of L-eflornithine-Based Therapy. <i>The AAPS journal</i> 24(3) 48–None. DOI:<a href=&quot;https://doi.org/10.1208/s12248-022-00693-2&quot;>10.1208/s12248-022-00693-2</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35338410/&quot;>https://pubmed.ncbi.nlm.nih.gov/35338410</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Nifurtimox;
